Simon Quick Advisors LLC lowered its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 12.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,072 shares of the company’s stock after selling 1,044 shares during the quarter. Simon Quick Advisors LLC’s holdings in Colgate-Palmolive were worth $643,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of the business. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive in the third quarter valued at approximately $42,000. Capital Performance Advisors LLP purchased a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at $53,000. Prospera Private Wealth LLC acquired a new position in Colgate-Palmolive during the 3rd quarter worth about $64,000. True Wealth Design LLC boosted its holdings in Colgate-Palmolive by 1,460.9% during the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after acquiring an additional 672 shares during the period. Finally, Continuum Advisory LLC grew its position in Colgate-Palmolive by 93.4% in the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock valued at $79,000 after acquiring an additional 368 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.
Colgate-Palmolive Trading Down 0.8 %
NYSE:CL opened at $87.53 on Thursday. The company has a market capitalization of $71.51 billion, a PE ratio of 25.08, a P/E/G ratio of 3.64 and a beta of 0.44. Colgate-Palmolive has a 52-week low of $80.03 and a 52-week high of $109.30. The stock’s 50 day moving average price is $92.07 and its 200 day moving average price is $97.65. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.
Colgate-Palmolive Announces Dividend
Insider Activity
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 0.37% of the company’s stock.
Analyst Upgrades and Downgrades
CL has been the subject of several recent research reports. JPMorgan Chase & Co. lowered their price objective on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a research note on Thursday, January 16th. Stifel Nicolaus dropped their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a research note on Friday, January 17th. TD Cowen cut their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Barclays decreased their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Finally, Piper Sandler reduced their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and an average target price of $101.11.
Get Our Latest Stock Analysis on Colgate-Palmolive
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- 3 Best Fintech Stocks for a Portfolio Boost
- Oracle Announces Game-Changing News for the AI Industry
- Breakout Stocks: What They Are and How to Identify Them
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Using the MarketBeat Dividend Tax Calculator
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.